Enhanced External Counterpulsaton(EECP): Shahid Gangalal Natonal Heart Center experience in frst nine patents
Journal Title: Nepalese Heart Journal - Year 2011, Vol 8, Issue 1
Abstract
Background EECP is a novel; FDA approved; non-invasive; outpatent treatment offered to patents with refractory angina pectoris (RAP).It uses sequentally inflated pneumatc cuffs on the lower extremites to enhance coronary diastolic flow. We studied its effect in eight patents with refractory angina pectoris. Methods All patents (n=9) who were referred for EECP to Shahid Gangalal Natonal Heart Centre who completed a treatment course (one hour per day for 35 days) of EECP and underwent 6-minute walk test before and afer treatment were included. Demographic data, coronary artery disease (CAD) risk factors and baseline angiographic data were collected. Distance covered in six minute walk test before and afer the treatment was compared. Results All the patents who had undergone EECP had a positve clinical response. Distance covered in Six minute walk test improved in all patents afer the treatment. Decrease in anginal severity, frequency and the use of sublingual nitrates, with improvement in quality of life was observed afer the treatment. During the treatment some patents complained of leg pain, one patent develops blister and one ecchymosis but the treatment was not discontnued. Conclusion The results from these patents suggest that EECP is an effectve, safe and well tolerated treatment opton for the patents with RAP.
Authors and Affiliations
Adhikari CM| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Prajapat D| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Rauniyar B| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,NepalDepartment of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, Maskey A| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal, KC MB| Department of Cardiology, Shahid Gangalal Natonal Heart Centre, Bansbari, Kathmandu,Nepal
Keywords
Related Articles
- EP ID EP15702
- DOI http://dx.doi.org/10.3126/njh.v8i1.8337
- Views 408
- Downloads 16
Percutaneous Transluminal Mitral Commisuriotomy for Mitral Stenosis in Shahid Gangalal National Heart Centre, Kathmandu, Nepal
Mitral stenosis (MS) is almost invariably the result of long term complication of rheumatic fever. Based upon the nature and severity of MS, patients can be managed with medical treatment, percutaneous transvenous mitr...
Predictors of in-hospital mortality following mitral or double valve replacement for rheumatic heart disease
Backgrounds and Aims: Factors affecting outcome of mitral valve replacement in rheumatic population of Nepal is unknown. The aim of this study was to identify the predictors of in-hospital mortality in patients undergo...
Acute ST segment elevaton MI with Normal Coronaries
A 45 year-old man with no history of cardiac disease presented to the emergency department with typical angina chest pain of >24 hours duraton. He was not thormbolyzed due to late presentaton. Having elevated troponin a...
Patern of Valvular Involvement and Demographic Features of Patents on Injecton Benzathine Penicillin at Dhulikhel Hospital
Background Rheumatc heart disease (RHD) is the most common cardiovascular disease in children and young adults. Though declined and almost non-existent in developed natons, RHD is stll one of the leading cause for prem...
Patterns of Valvular Involvement in Rheumatic Heart Disease patients taking Benzathine Penicillin at Shahid Gangalal National Heart Centre, Kathmandu, Nepal
Background and Aims: Acute rheumatic fever and rheumatic heart disease constitute an important public health problem in the developing countries. The disease results from an abnormal autoimmune response to a group A st...